Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ohe

Showing results (101-110 of 191) with videos related to

Pageof 20
Sort By:
Nihon Kyobu Shikkan Gakkai Zasshi|February 1, 1991
[The relation between myelotoxicity and performance status or aging in chemotherapy of non-small cell lung cancer]F Oshita, T Shinkai, T Miya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Serum levels of cytokines in patients with untreated primary lung cancerN Katsumata, K Eguchi, M Fukuda, et al.
Anticancer Research|January 1, 1997
Chronopharmacology of etoposide given by low dose prolonged infusion in lung cancer patientsN Yamamoto, T Tamura, Y Ohe, et al.
International Journal of Cancer|July 27, 1999
Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivoH Fukumoto, K Nishio, S Ohta, et al.
Journal of Immunoassay|January 1, 1990
Monoclonal antibody to pseudouridine used to develop a radioimmunoassayY Ohe, T Nishino, S Shin, et al.
Hepato-Gastroenterology|October 1, 1994
Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinomaM Suga, A Senota, K Arima, et al.
Diabetologia|April 1, 1988
Specific radioimmunoassay of glucitol-lysine--application to lens proteins in streptozotocin-diabetic ratsM Yano, F Hashimoto, M Sato, et al.
Oncology|January 1, 1990
Lack of correlation between interferon levels induced by polyribonucleotides and their antimetastatic effectM Sakurai, M Iigo, Y Sasaki, et al.
Cancer Research|March 1, 1991
Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusionY Sasaki, T Amano, M Morita, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1989
Inhibition of colony formation of drug-resistant human tumor cell lines by combinations of interleukin-2-activated killer cells and antitumor drugsA Ohtsu, Y Sasaki, T Tamura, et al.
Pageof 20

Showing results (101-110 of 191) with videos related to

Sort By:
Pageof 20
Nihon Kyobu Shikkan Gakkai Zasshi|February 1, 1991
[The relation between myelotoxicity and performance status or aging in chemotherapy of non-small cell lung cancer]F Oshita, T Shinkai, T Miya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Serum levels of cytokines in patients with untreated primary lung cancerN Katsumata, K Eguchi, M Fukuda, et al.
Anticancer Research|January 1, 1997
Chronopharmacology of etoposide given by low dose prolonged infusion in lung cancer patientsN Yamamoto, T Tamura, Y Ohe, et al.
International Journal of Cancer|July 27, 1999
Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivoH Fukumoto, K Nishio, S Ohta, et al.
Journal of Immunoassay|January 1, 1990
Monoclonal antibody to pseudouridine used to develop a radioimmunoassayY Ohe, T Nishino, S Shin, et al.
Hepato-Gastroenterology|October 1, 1994
Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinomaM Suga, A Senota, K Arima, et al.
Diabetologia|April 1, 1988
Specific radioimmunoassay of glucitol-lysine--application to lens proteins in streptozotocin-diabetic ratsM Yano, F Hashimoto, M Sato, et al.
Oncology|January 1, 1990
Lack of correlation between interferon levels induced by polyribonucleotides and their antimetastatic effectM Sakurai, M Iigo, Y Sasaki, et al.
Cancer Research|March 1, 1991
Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusionY Sasaki, T Amano, M Morita, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1989
Inhibition of colony formation of drug-resistant human tumor cell lines by combinations of interleukin-2-activated killer cells and antitumor drugsA Ohtsu, Y Sasaki, T Tamura, et al.
Pageof 20